- Current report filing (8-K)
18 November 2009 - 6:22AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of
Report (Date of earliest event reported): November 17,
2009
REMEDENT,
INC.
(Exact
name of registrant as specified in its charter)
Nevada
|
001-15975
|
86-0837251
|
(State
or Other Jurisdiction of
|
(Commission
File Number)
|
(IRS
Employer
|
Incorporation)
|
|
Identification
No.)
|
Xavier de Cocklaan 42, 9831, Deurle,
Belgium
|
N/A
|
(Address
of Principal Executive Offices)
|
(Zip
Code)
|
011-329-321-70-80
(Registrant's
telephone number, including area code)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Section 2 – Financial
Information
Item
2.02 Results of Operations and Financial Condition.
On November 17, 2009, the Company
issued a press release reporting its financial results for the fiscal second
quarter ended September 30, 2009, and announcing a conference call to discuss
the results on Thursday, November 19, 2009.
A copy of the press release is attached
hereto as Exhibit 99.1 and incorporated herein by
reference.
Section 7 –
Regulation FD
Item
7.01. Regulation FD Disclosure
On November 17, 2009, the
Company issued a press release reporting its
financial
results for the fiscal second quarter ended September 30, 2009, and
announcing the launch of its new corporate website and a conference
call to discuss the financial results on Thursday, November 19,
2009.
A copy of the press release is attached
hereto as Exhibit 99.1 and incorporated herein by reference.
Section 9 – Financial
Statements and Exhibits
Item
9.01 Financial Statements and Exhibits.
Exhibit No.
|
|
Exhibit Description
|
|
|
|
99.1
|
|
Press
Release dated November 17,
2009
|
The
information set forth under Items 2.02 and 7.01 of this Form 8-K and Exhibit
99.1attached hereto are furnished and shall not be deemed “filed” for purposes
of Section 18 of the Securities Exchange Act of 1934, and shall not be deemed
incorporated by reference in any filing with the Securities and Exchange
Commission under the Securities Exchange Act of 1934 or the Securities Act of
1933, whether made before or after the date hereof and irrespective of any
general incorporation by reference language in any filing.
Portions
of this report constitute “forward-looking statements” defined by federal
law. Although the Company believes any such statements are based on
reasonable assumptions, there is no assurance that the actual outcomes will not
be materially different. Any such statements are made in reliance on the “safe
harbor” protections provided under the Private Securities Litigation Reform Act
of 1995. Additional information about issues that could lead to material changes
in the Company’s performance is contained in the Company’s filings with the
Securities and Exchange Commission and may be accessed at
www.sec.gov.
SIGNATURE
Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly
authorized.
|
REMEDENT,
INC.,
|
|
a
Nevada corporation
|
|
|
|
Dated:
November 17, 2009
|
By:
|
/s/
Stephen
Ross
|
|
|
Stephen
Ross
|
|
|
Chief
Financial Officer
|
Elysee Development (PK) (USOTC:ASXSF)
Historical Stock Chart
From Jun 2024 to Jul 2024
Elysee Development (PK) (USOTC:ASXSF)
Historical Stock Chart
From Jul 2023 to Jul 2024